William J. Newell

2021

In 2021, William J. Newell earned a total compensation of $5.6M as Chief Executive Officer at SUTRO BIOPHARMA, a 161% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$393,750
Option Awards$2,994,000
Salary$625,000
Stock Awards$1,583,250
Other$37,678
Total$5,633,678

Newell received $3M in option awards, accounting for 53% of the total pay in 2021.

Newell also received $393.8K in non-equity incentive plan, $625K in salary, $1.6M in stock awards and $37.7K in other compensation.

Rankings

In 2021, William J. Newell's compensation ranked 2,263rd out of 12,415 executives tracked by ExecPay. In other words, Newell earned more than 81.8% of executives.

ClassificationRankingPercentile
All
2,263
out of 12,415
82nd
Division
Manufacturing
884
out of 5,505
84th
Major group
Chemicals And Allied Products
338
out of 2,375
86th
Industry group
Drugs
292
out of 2,096
86th
Industry
Biological Products, Except Diagnostic Substances
91
out of 449
80th
Source: SEC filing on April 22, 2022.

Newell's colleagues

We found four more compensation records of executives who worked with William J. Newell at SUTRO BIOPHARMA in 2021.

2021

Jane Chung

SUTRO BIOPHARMA

Chief Commercial Officer

2021

Trevor Hallam

SUTRO BIOPHARMA

Chief Scientific Officer

2021

Arturo Molina

SUTRO BIOPHARMA

Chief Medical Officer

2021

Edward Albini

SUTRO BIOPHARMA

Chief Financial Officer

News

In-depth

You may also like